Mukka Proteins Stock Plummets to New 52-Week Low at Rs. 25

Mukka Proteins, a microcap player in the FMCG sector, has reached a new 52-week low, trading at Rs. 25 on October 16, 2025. This significant decline highlights the company's ongoing struggles, as it has underperformed its sector by 5.41% today. The stock has consistently traded below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a persistent downward trend. In contrast, the broader market, represented by the Sensex, has shown resilience, climbing to 83,063.67 points, just 1.25% shy of its 52-week high. Mukka Proteins' performance over the past year has been notably poor, with a decline of 41.77%, while the Sensex has gained 1.90% during the same period. The company's financial metrics reveal challenges, including a low Return on Capital Employed (ROCE) of 9.48% and a high Debt to EBITDA ratio of 4.36 times, suggesting difficulties in managing debt and profitability. Additionally, Mukka Proteins has reported negative results for six consecutive quarters, with net sales falling by 32.1% compared to previous averages. This combination of factors has contributed to a decline in institutional investor participation, further complicating the company's market position.